Member Info for wadogara

Sellers getting robbed if they don't jump right back in now

Expecting a strong rebound from tomorrow afternoon, fomo will kick in for next week

Too much value in this , temporarily being held back by new share admissin, but it's gonna be one of those stocks that multiply once the new shares have churned..if not already foreard sold.

Next week will see plenty of 🚀🚀🚀🚀

Sellers robbed, the market knows there's life in this old dog yet 🚀

This could keep going for days 🚀

@ 8.30 and 9.15

£14k and £13k

That u @ shrewdie ?

We already have the banking license..with Albaco

It's the tie-in with CHP and the launch of an international financial investment company that we're waiting for.

Name an international financial investment company/bank with a couple of £mn mcap ?..exactly 🚀🚀🚀

Hi p-bob

What's this 68 billion u speak of ?

Hi Laura

Already in there with a punt

Not sure how this one is gonna play out tho

40% dilution @ 2.5p and peeps still buying🤔

Threw in a few this mornin myself, just incase somethin silly happens 😄

0.00548 obvious buys showing as sells 🙄

I'd b careful @ Tiger, may be some forward selling by placees here

Here's to another solid day

News simply HAS to be v close 🚀

Just checked

Sorry, the bookbuild/retail offer has already closed..see RNS 23rd.. so the cheap ones are gone ( hectic day )

Shareholders will have an opportunity to buy, but only in the retail offer part..can't check right now but it will b a small percentage of total raise.

SP tends to drift back towards raise price as it nears admission date

It can then ..and v often does..fly north afterwards if news is there to support it. Good news is certainly here, just a pity it didn't come after the 25th.

Raise is conditional on shareholder approval at the GM on the 23rd June

...that the recent fundraise means approx. 40% dilution @ 2.5p is coming upon new share admission on 25th June ?

Yes ,i championed this all day but really surprised how high it went considering the above..and equally surprised that nobody has mentioned these new shares all day.

Personally, i would use caution here, and intend to return closer to June 25th.

I may miss the baot by then, who knows, but a 40% drag @ 2.5p is bound to take affect imo.

I know what it's like to be spiked..many times..so just a word of temporary caution.

If u can hold thru the volatility then i still expect it will be in the 7-8p range post admission.

Magnificent day here, looking v strong indeed on run to news.

People always bemoan the mention of other stocks on bb's.

No harm in spreading good news i say

I know i've mentioned this share alot in recent days on other boards and hooefully some who are now invested will reap the rewards.

I know i did when i spotted POLB getting a mention this morning somewhere.

It's impossible to keep track of all the daily news so i for one am often glad to hear of some tips elsewhere.

Can't wait to see what's in store here.

Thanks @cobblersdaughter

0.1 is just a 20 x bagger away so i can wait..2 weeks 😉😆

Anyone else's h/l account showing over +120% on these all of a sudden ? I'm in profit, but defo not that much !

When u know u know i suppose 😄

Artificial intelligence programmes - The Company collaborated with AI experts, CytoReason for influenza and OneThree Biotech for Respiratory Syncytial Virus ("RSV"), to build and lead two AI programmes, utilizing Poolbeg Pharma's licenced proprietary multi-parametric human challenge trial data. These programmes successfully identified valuable novel drug targets and new potential drug candidates representing potential new classes of therapy for the treatment of influenza and RSV.

The depth and precision of human challenge trial data has revolutionised AI-driven insights, identifying host-response-based targets that could halt or slow disease progression, with reduced risk of viral resistance which is a critical challenge in the development of treatments for respiratory viral diseases.

Following the successful prioritization of candidates in late 2023, discussions regarding potential collaborations are ongoing. AI-driven drug discovery continues to attract global interest due to its potential to accelerate target identification, reduce costs, de-risk development, and improve success rates.

Looks like the herd have finally heard @disco

Just have to wait for the market to wake up disco, then we dance 🕺

..and exec.chair pumping £100k in